These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 28356729

  • 1. Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50-64 years, the SCAPIS Pilot Study.
    Torén K, Bake B, Olin AC, Engström G, Blomberg A, Vikgren J, Hedner J, Brandberg J, Persson HL, Sköld CM, Rosengren A, Bergström G, Janson C.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [Abstract] [Full Text] [Related]

  • 2. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K, Olin AC, Lindberg A, Vikgren J, Schiöler L, Brandberg J, Johnsson Å, Engström G, Persson HL, Sköld M, Hedner J, Lindberg E, Malinovschi A, Piitulainen E, Wollmer P, Rosengren A, Janson C, Blomberg A, Bergström G.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [Abstract] [Full Text] [Related]

  • 3. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V, Gálffy G, Orosz M, Kováts Z, Odler B, Selroos O, Tamási L.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [Abstract] [Full Text] [Related]

  • 5. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y, Shaaban R, Al-Zahab BA, Khaltaev N, Bousquet J, Dubaybo B.
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [Abstract] [Full Text] [Related]

  • 6. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.
    Torén K, Murgia N, Olin AC, Hedner J, Brandberg J, Rosengren A, Bergström G.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2269-2275. PubMed ID: 28831247
    [Abstract] [Full Text] [Related]

  • 7. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P, Dahl R, Løkke A, Ulrik CS.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [Abstract] [Full Text] [Related]

  • 8. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K, Vikgren J, Olin AC, Rosengren A, Bergström G, Brandberg J.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A, Hughes R, Del Olmo R, Agusti A, Chipps BE, Make B, Tomaszewski E, Peres Da Costa K, Srivastava D, Vestbo J, Janson C, Burgel PR, Price D.
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [Abstract] [Full Text] [Related]

  • 11. Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
    Janson C, Malinovschi A, Amaral AFS, Accordini S, Bousquet J, Buist AS, Canonica GW, Dahlén B, Garcia-Aymerich J, Gnatiuc L, Kowalski ML, Patel J, Tan W, Torén K, Zuberbier T, Burney P, Jarvis D.
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221806
    [Abstract] [Full Text] [Related]

  • 12. Bronchodilator responsiveness and reported respiratory symptoms in an adult population.
    Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, Aaron S, Marciniuk DD, Maltais F, Buist AS, O'Donnell DE, Sin DD, CanCOLD Collaborative Research Group.
    PLoS One; 2013 Sep; 8(3):e58932. PubMed ID: 23554960
    [Abstract] [Full Text] [Related]

  • 13. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S, Dirican A, Tuna T.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep; 11():2009-15. PubMed ID: 27616884
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM.
    Int J Chron Obstruct Pulmon Dis; 2008 Sep; 3(4):693-9. PubMed ID: 19281083
    [Abstract] [Full Text] [Related]

  • 15. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
    Fortis S, Comellas AP, Bhatt SP, Hoffman EA, Han MK, Bhakta NR, Paine R, Ronish B, Kanner RE, Dransfield M, Hoesterey D, Buhr RG, Barr RG, Dolezal B, Ortega VE, Drummond MB, Arjomandi M, Kaner RJ, Kim V, Curtis JL, Bowler RP, Martinez F, Labaki WW, Cooper CB, O'Neal WK, Criner G, Hansel NN, Krishnan JA, Woodruff P, Couper D, Tashkin D, Barjaktarevic I.
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [Abstract] [Full Text] [Related]

  • 16. Second-order Texture Measurements of (3)He Ventilation MRI: Proof-of-concept Evaluation of Asthma Bronchodilator Response.
    Zha N, Pike D, Svenningsen S, Capaldi DP, McCormack DG, Parraga G.
    Acad Radiol; 2016 Feb; 23(2):176-85. PubMed ID: 26601971
    [Abstract] [Full Text] [Related]

  • 17. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA, Waterman LA, Ward J, Gifford AH.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [Abstract] [Full Text] [Related]

  • 18. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H, Préfaut C, Tabka Z, Zbidi A, Hayot M.
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [Abstract] [Full Text] [Related]

  • 19. [Spirometric reversibility to salbutamol in chronic obstructive pulmonary disease (COPD). Differential effects on FEV1 and on lung volumes].
    Manríquez J, Díaz O, Borzone G, Lisboa C.
    Rev Med Chil; 2004 Jul; 132(7):787-93. PubMed ID: 15379324
    [Abstract] [Full Text] [Related]

  • 20. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
    Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, Kim EK, Lee YK, Kim TH, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Oh YM, Lee SD.
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.